Skip to content

Author

W. Al-khfajy

We have 1 of 10 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

RRx-001 Accelerates Low Dose Oxaliplatin-Induced Cytotoxicity in Triple-Negative Breast Cancer Cells via Synergistic Antitumor Mechanisms

Background: Triple-negative breast cancer (TNBC) represents an aggressive subtype that has few therapeutic options for targeting and is highly resistant to chemotherapy. The compound RRx-001 is a dinitroazetidine compound with both immune-modulating and epigenetic properties, whereas oxaliplatin elicits immunogenic cel...

R. K. Al-Fatlawi, W. Al-khfajy · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.